- Evommune filed Form 8-K (Item 7.01) announcing a webcast on in-licensed oral VAV1-directed degrader EVO570.
- Worldwide rights outside Greater China obtained from Hinova Pharmaceuticals.
- Routine IR event with no new clinical data or updated financial figures.
Signal #143708 · SEC 8-K
$EVMN SEC Filing Alert & Real-Time AI Stock Impact Analysis
Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).
FAQ: $EVMN filing catalyst
Why did $EVMN trigger an AI stock catalyst alert?
$EVMN triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: +0.5/10). Headline: Evommune Hosts Webcast on In-Licensed Molecule EVO570. Key points: - Evommune filed Form 8-K (Item 7.01) announcing a webcast on in-licensed oral VAV1-directed degrader EVO570. - Worldwide rights outside Greater China obtained from Hinova Pharmaceuticals. - Routine IR event with no new clinical data or updated financial figures.
How did $EVMN stock react after the SEC filing?
After the SEC 8-K for $EVMN, observed market reaction: T0 price $6.04. Past moves do not guarantee future results.
Where can I get real-time $EVMN SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $EVMN via Telegram and the VIP Web Terminal from €10/month.